hydroxyl radical has been researched along with apomorphine in 5 studies
| Studies (hydroxyl radical) | Trials (hydroxyl radical) | Recent Studies (post-2010) (hydroxyl radical) | Studies (apomorphine) | Trials (apomorphine) | Recent Studies (post-2010) (apomorphine) |
|---|---|---|---|---|---|
| 10,147 | 26 | 3,657 | 9,205 | 287 | 780 |
| Protein | Taxonomy | hydroxyl radical (IC50) | apomorphine (IC50) |
|---|---|---|---|
| Tryptophan 5-hydroxylase 1 | Rattus norvegicus (Norway rat) | 0.22 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.0146 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 7.75 | |
| D | Rattus norvegicus (Norway rat) | 0.4744 | |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.1432 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.063 | |
| D(2) dopamine receptor | Bos taurus (cattle) | 0.3385 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 0.025 | |
| D(4) dopamine receptor | Homo sapiens (human) | 0.025 | |
| D(1B) dopamine receptor | Homo sapiens (human) | 0.025 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.063 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.063 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 7.75 | |
| D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.1432 | |
| D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.1432 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.025 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 7.75 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0813 | |
| E3 ubiquitin-protein ligase Mdm2 | Homo sapiens (human) | 0.205 | |
| 5-hydroxytryptamine receptor 4 | Rattus norvegicus (Norway rat) | 1.35 | |
| D | Bos taurus (cattle) | 0.3385 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcaraz, MJ; Montesinos, C; Payá, M; Ubeda, A | 1 |
| Chen, YK; Lin, HC; Liu, JC; Wan, FJ | 1 |
| Andreazza, AC; Salvador, M; Soares, DG | 1 |
| Beley, A; Bertrand, N; Demougeot, C; Garnier, P; Guilland, JC; Marie, C; Méthy, D; Prigent-Tessier, A | 1 |
| Karuppagounder, SS; Madathil, SK; Mohanakumar, KP | 1 |
5 other study(ies) available for hydroxyl radical and apomorphine
| Article | Year |
|---|---|
Iron-reducing and free-radical-scavenging properties of apomorphine and some related benzylisoquinolines.
Topics: Animals; Apomorphine; Copper; Cytochrome c Group; Deoxyribose; DNA Damage; Edetic Acid; Ferric Compounds; Free Radical Scavengers; Free Radicals; Hydrogen Peroxide; Hydroxides; Hydroxyl Radical; Iron; Isoquinolines; Lipid Peroxidation; Microsomes, Liver; Oxidation-Reduction; Peroxides; Rats; Superoxides | 1993 |
Potent, hydroxyl radical-scavenging effect of apomorphine with iron and dopamine perfusion in rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Corpus Striatum; Dopamine; Dopamine Agonists; Free Radical Scavengers; Hydroxybenzoates; Hydroxyl Radical; Iron; Male; Microdialysis; Rats; Rats, Sprague-Dawley | 2001 |
Sequestering ability of butylated hydroxytoluene, propyl gallate, resveratrol, and vitamins C and E against ABTS, DPPH, and hydroxyl free radicals in chemical and biological systems.
Topics: Antioxidants; Apomorphine; Ascorbic Acid; Benzothiazoles; beta Carotene; Biphenyl Compounds; Butylated Hydroxytoluene; Hydrogen Peroxide; Hydroxyl Radical; Oxidation-Reduction; Paraquat; Picrates; Propyl Gallate; Resveratrol; Saccharomyces cerevisiae; Stilbenes; Sulfonic Acids; Vitamin E | 2003 |
Effects of a direct injection of liposoluble iron into rat striatum. Importance of the rate of iron delivery to cells.
Topics: Animals; Apomorphine; Cell Death; Cells, Cultured; Corpus Striatum; Endothelium, Vascular; Ferric Compounds; Hydroxyl Radical; Hydroxyquinolines; Injections; Iron; Lipid Peroxidation; Male; Rats; Rats, Wistar; Solubility | 2003 |
Sodium salicylate protects against rotenone-induced parkinsonism in rats.
Topics: Amphetamine; Animals; Apomorphine; Corpus Striatum; Cyclooxygenase Inhibitors; Dopamine; Dose-Response Relationship, Drug; Electron Transport Complex I; Glutathione; Hydroxyl Radical; Male; Neurons; Oxidative Stress; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Rotenone; Sodium Salicylate; Substantia Nigra; Superoxide Dismutase; Uncoupling Agents | 2013 |